Carnem
ActiveSummary
Carnem has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €227,133 and a net result of €53,274. Equity is growing by about 46% per year across the filed financial years. Its solvency ranks better than 79% of 13,632 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-03
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Liquidity more than doubledcurrent ratio 4.37
Current ratio from 2.10 to 4.37; short-term debt falls from €182,994 to €65,166.
25-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Highest result from 2019 to 2025net €87,039 ▲93.6%
Operating result €129,222, net result €87,039, both a record.
31-12
Financial
Equity above €200,000equity €227,133 ▲62.1%
5 profitable years in a row build equity to €227,133.
05-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Liquidity more than doubledcurrent ratio 3.72
Current ratio from 1.63 to 3.72; short-term debt falls from €74,016 to €73,930.
31-12
Financial
Equity above €100,000equity €140,095 ▲47.2%
4 profitable years in a row build equity to €140,095.
27-06
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
14-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
14-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
31-12
Financial
Back to profitnet €14,359
Net result €14,359 after one loss-making year.
26-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.